[144] Vericel Corporation SEC Filing

Rhea-AI Filing Summary

Form 144 filing for Vericel Corporation (VCEL) shows a planned sale of 10,000 common shares held by the reporting person through Fidelity Brokerage Services. The filing lists an approximate aggregate market value of $357,700 for the shares to be sold and indicates the shares represent part of an option granted on 02/11/2020 and acquired on 09/02/2025, with cash payment at exercise. The issuer's total shares outstanding are shown as 50,460,205, so the proposed block is a small fraction of the company. The filing also discloses a prior sale of 10,000 common shares by the same person on 06/02/2025 for $400,924. The notice affirms the signer does not possess undisclosed material adverse information.

Positive

• Clear compliance disclosure under Rule 144 with broker, quantity, and market value specified
• Exercise details provided: option granted 02/11/2020 and acquired/exercised 09/02/2025 with cash payment
• Prior sale disclosed for transparency: 10,000 shares sold 06/02/2025 for $400,924

Negative

• None.

Insights

Securities/Equity Analyst

TL;DR: Routine insider notice of intended sale; size is immaterial relative to outstanding shares and follows a recent sale.

The Form 144 documents an intended sale of 10,000 common shares via a broker with an aggregate market value of $357,700. Given the issuer's stated 50.46 million shares outstanding, the planned sale represents roughly 0.02% of outstanding shares, which is immaterial from a market-capitalization perspective. The filing also records a prior sale of 10,000 shares on 06/02/2025 for $400,924, confirming recent liquidity activity by the same individual. This filing meets disclosure requirements under Rule 144 and provides transparency but does not, by itself, indicate a material change to the company's capital structure or operations.

Corporate Governance Expert

TL;DR: Properly executed insider disclosure; affirms compliance with Rule 144 and includes representation about material nonpublic information.

The notice includes required seller and broker details, the acquisition method (option granted 02/11/2020, exercised 09/02/2025), and the signature attestation regarding material adverse information. It also lists prior sales within three months, satisfying aggregation and reporting rules. From a governance perspective, the filing documents procedural compliance and transparency by the reporting person, without revealing any new governance actions or changes in management holdings beyond the disclosed sales.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	10000	357700.00	50460205	09/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/02/2025	Option Granted - 02/11/2020	Issuer			10000	09/02/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jonathan M. Hopper 64 Sidney Street Cambridge MA 02139	Common	06/02/2025	10000	400924.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Vericel Corporation's (VCEL) Form 144 report?

The Form 144 reports an intended sale of 10,000 common shares through Fidelity with an aggregate market value of $357,700.

How many shares of VCEL are outstanding according to the filing?

The filing lists 50,460,205 shares outstanding.

When were the securities acquired and how were they obtained?

The shares were reported as acquired on 09/02/2025 via exercise of an option granted on 02/11/2020, paid in cash.

Did the filer sell VCEL shares recently?

Yes. The filing discloses a sale of 10,000 common shares on 06/02/2025 for $400,924.

What attestation does the filer make in the Form 144?

The filer represents by signing that they do not know any material adverse information about the issuer that has not been publicly disclosed.